IMARC Group, a leading market research company, has recently released a report titled “Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global blood culture test market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
What Are The Growth Prospects Of The Blood Culture Test Industry?
According to the report, The global blood culture test market size reached US$ 4.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
What is Blood Culture Test?
A blood culture test is a medical diagnostic procedure to identify bacterial, fungal, and mycobacterial infections. Its purpose is to detect the presence of various microorganisms in a blood sample and prevent the development of sepsis, a life-threatening condition. The test involves using blood culture media, assay kits, reagents, accessories, automated blood culture systems, and supporting laboratory equipment. At present, blood culture tests find extensive applications in determining the specific pathogens responsible for the infection and the potential ways to combat the disease across the globe.
Request for a sample copy of this report: https://www.imarcgroup.com/blood-culture-test-market/requestsample
What are the growth prospects and trends in the blood culture test industry?
The global blood culture test market is primarily driven by the rising prevalence of chronic and infectious diseases. Moreover, the increasing geriatric population, which is more susceptible to sepsis and other medical conditions, is positively influencing the market growth. Additionally, the surging use of blood culture tests by laboratories, diagnostic centers, and other healthcare institutes to detect the presence of antibodies in the blood, identify infected individuals, and prevent the spread of the disease has catalyzed market growth. Furthermore, the escalating demand for blood culture tests amid the sudden outbreak of the coronavirus (COVID-19) pandemic to analyze specimens is contributing to the market growth. Other factors, including extensive research and development (RD) activities in the medical sciences, rising health awareness among the masses, and improvements in healthcare infrastructure, are also anticipated to drive the market further.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Abbott Laboratories (ABT)
Beckman Coulter ( BEC )
BD (Becton, Dickinson and Company) (NYSE:BDX)
BIOMERIEUX (BIM.PA)
Bruker Corporation (BRKR)
Cepheid (NASDAQ:CPHD). (Danaher Corporation)
Luminex Corporation
Merck Group
Siemens Healthineers AG
Roche Diagnostics
T2 Biosystems, Inc. (TTOO)
Thermo Fisher Scientific Inc. (NYSE: TMO)
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=reportid=2275flag=F
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Testing Method:
Conventional
Automated
Breakup by Product:
Consumables
Blood Culture Media
Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Fungi/Yeast Blood Culture Media
Mycobacteria Blood Culture Media
Assay Kits and Reagents
Blood Culture Accessories
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Services
Breakup by Technology:
Culture-based Technology
Molecular Technology
Microarray
PCR
PNA-FISH
Proteomic Technology
Others
Breakup by Application:
Bacterial Infection
Fungal Infection
Mycobacterial Infection
Breakup by End-User:
Hospital Laboratories
Reference Laboratories
Research Laboratories
Others
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal